CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
766-780 of 1196
Renato D. Lopes, MD, MHS, PhD
Don't Miss It! Rapid & Accurate AAV Diagnosis
MinuteCE®Don't Miss It! Rapid & Accurate AAV Diagnosis
Silke R. Brix, MD, MRCP, SCPR
Andreas Kronbichler, MD
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
MinuteCE®How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
Alexander T. Cohen, MD, MBBS
Bernhard Hellmich, MD
Andreas Kronbichler, MD
Silke R. Brix, MD, MRCP, SCPR
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
MinuteCE®How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
Renato D. Lopes, MD, MHS, PhD
Valeria Caso, MD, PhD
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
MinuteCE®Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
Valeria Caso, MD, PhD
- advertisement
Renato D. Lopes, MD, MHS, PhD
Valeria Caso, MD, PhD
GA Cases in the Primary Eye Care Clinic: Can You Spot the Three Signs?
CME/CEGA Cases in the Primary Eye Care Clinic: Can You Spot the Three Signs?
Yasha S. Modi, MD, MHS
Danny Mammo, MD
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
CME/CEAdvancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
Javier Cortes, MD, PhD
Hope S. Rugo, MD, FASCO
Carey Anders, MD, FASCO
Sarah Sammons, MD
Applying Data Into Practice: Sequencing Strategies for HER2-Targeted Breast Cancer
MinuteCE®Applying Data Into Practice: Sequencing Strategies for HER2-Targeted Breast Cancer
Carey Anders, MD, FASCO
Sarah Sammons, MD
HER2-Targeted TKI Combinations in Second-Line and Beyond MBC
MinuteCE®HER2-Targeted TKI Combinations in Second-Line and Beyond MBC
Sarah Sammons, MD
- advertisement
Recent Updates in HER2-Targeted TKIs for Metastatic Breast Cancer
MinuteCE®Recent Updates in HER2-Targeted TKIs for Metastatic Breast Cancer
Sarah Sammons, MD
Differentiating Agents in the Expanding HER2-Targeted Arsenal for Metastatic Breast Cancer
MinuteCE®Differentiating Agents in the Expanding HER2-Targeted Arsenal for Metastatic Breast Cancer
Carey Anders, MD, FASCO
Sarah Sammons, MD
Systemic Management of Brain Metastases in HER2+ BC: Emerging Strategies and Treatment Approaches
MinuteCE®Systemic Management of Brain Metastases in HER2+ BC: Emerging Strategies and Treatment Approaches
Carey Anders, MD, FASCO
